Moreover, Wang et al.’s recent study showed that patients with poor UDCA response had decreased butyrate levels, and butyrate could improve cholangitis by inhibiting HDAC3 in myeloid-derived suppressor cells (MDSCs), enhancing acetylation of histone H3 lysine 27 (Wang et al., 2024). Here, HDAC3 is linked to cholangitis.